Tags

Type your tag names separated by a space and hit enter

Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Platelets. 2022 Nov 17; 33(8):1260-1269.P

Abstract

Patients have a high risk of suffering adverse reactions after receiving platelet products stored for 5 days. Bioactive exosomes in platelet products can be accumulated during storage, which is associated with adverse reactions. MicroRNAs are one of the critical cargoes in exosomes, which participate in cell differentiation, metabolism, and immunomodulation. This study intends to elucidate and analyze the differential expression of exosomal microRNAs in apheresis platelet concentrates during storage and predict the potential functions of target genes. Apheresis platelet concentrates were used to isolate exosomes by ultracentrifugation. Exosomes were phenotyped by western blot, transmission electron microscopy, and nano flow cytometry. The differential expression of the exosomal microRNAs was obtained by a microarray test using four bags of apheresis platelets stored for 5 days compared with 1 day. The differentially expressed microRNAs between the two time points were identified, and their target genes were analyzed by miRWalk and miRDB. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to predict the target genes' functions. Fifteen bags of apheresis platelet concentrates stored for 1 day and 5 days were used to verify the microarray results by quantitative reverse transcription-polymerase chain reactions (qRT-PCR). There were 134 microRNAs in total expressed differently in the two groups (day 1 and day 5), with 57 microRNAs up-regulated and 77 down-regulated (|fold change| > 2.0 and P < .05). Thirteen up-regulated microRNAs (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, hsa-miR-320b, hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, hsa-miR-320c, hsa-miR-342-3p, hsa-miR-320d, hsa-miR-328-3p, and hsa-miR-320e) detected in all samples were selected to validate the results. The qRT-PCR results showed that five (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, and hsa-miR-320b) of them were increased more than 10-fold (P < .001); four (hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, hsa-miR-320c) more than five-fold (P < .001); two (hsa-miR-342-3p and hsa-miR-320d) more than two-fold (P < .05); and two (hsa-miR-328-3p and hsa-miR-320e) more than two-fold (P > .05). Specifically, hsa-miR-22-3p increased 14.6-fold; hsa-miR-223-3p increased 13.0-fold; and hsa-miR-21-5p increased 12.0-fold. Based on bioinformatics functional analysis, target genes of top nine microRNAs (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, hsa-miR-320b, hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, and hsa-miR-320c) were annotated with positive regulation of cell proliferation and nervous system development, and mainly enriched in regulating pluripotency of stem cells signaling pathway, prolactin signaling pathway, and FoxO signaling pathway, etc. The prolactin, FoxO, ErbB, and TNF signaling pathway were relevant to immunomodulation. In particular, hsa-miR-22-3p expression was the most different during storage, with a fold change of 14.6, which might be a key mediator.

Authors+Show Affiliations

Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China. School of Public Health, Anhui Medical University, Hefei, AH, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, SC, China. Key Laboratory of Transfusion Adverse Reactions, Institute of Blood Transfusion, Chinese Academy of Medical Sciences, Chengdu, SC, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

35968647

Citation

Mi, Ziyue, et al. "Differential Expression of Exosomal microRNAs in Fresh and Senescent Apheresis Platelet Concentrates." Platelets, vol. 33, no. 8, 2022, pp. 1260-1269.
Mi Z, Gong L, Kong Y, et al. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates. Platelets. 2022;33(8):1260-1269.
Mi, Z., Gong, L., Kong, Y., Zhao, P., Yin, Y., Xu, H., Tian, L., & Liu, Z. (2022). Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates. Platelets, 33(8), 1260-1269. https://doi.org/10.1080/09537104.2022.2108541
Mi Z, et al. Differential Expression of Exosomal microRNAs in Fresh and Senescent Apheresis Platelet Concentrates. Platelets. 2022 Nov 17;33(8):1260-1269. PubMed PMID: 35968647.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates. AU - Mi,Ziyue, AU - Gong,Li, AU - Kong,Yujie, AU - Zhao,Peizhe, AU - Yin,Yonghua, AU - Xu,Haixia, AU - Tian,Li, AU - Liu,Zhong, Y1 - 2022/08/14/ PY - 2022/8/16/pubmed PY - 2022/10/12/medline PY - 2022/8/15/entrez KW - Apheresis platelet KW - differential expression profiling KW - exosome KW - immunomodulation KW - microRNA KW - storage time SP - 1260 EP - 1269 JF - Platelets JO - Platelets VL - 33 IS - 8 N2 - Patients have a high risk of suffering adverse reactions after receiving platelet products stored for 5 days. Bioactive exosomes in platelet products can be accumulated during storage, which is associated with adverse reactions. MicroRNAs are one of the critical cargoes in exosomes, which participate in cell differentiation, metabolism, and immunomodulation. This study intends to elucidate and analyze the differential expression of exosomal microRNAs in apheresis platelet concentrates during storage and predict the potential functions of target genes. Apheresis platelet concentrates were used to isolate exosomes by ultracentrifugation. Exosomes were phenotyped by western blot, transmission electron microscopy, and nano flow cytometry. The differential expression of the exosomal microRNAs was obtained by a microarray test using four bags of apheresis platelets stored for 5 days compared with 1 day. The differentially expressed microRNAs between the two time points were identified, and their target genes were analyzed by miRWalk and miRDB. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to predict the target genes' functions. Fifteen bags of apheresis platelet concentrates stored for 1 day and 5 days were used to verify the microarray results by quantitative reverse transcription-polymerase chain reactions (qRT-PCR). There were 134 microRNAs in total expressed differently in the two groups (day 1 and day 5), with 57 microRNAs up-regulated and 77 down-regulated (|fold change| > 2.0 and P < .05). Thirteen up-regulated microRNAs (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, hsa-miR-320b, hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, hsa-miR-320c, hsa-miR-342-3p, hsa-miR-320d, hsa-miR-328-3p, and hsa-miR-320e) detected in all samples were selected to validate the results. The qRT-PCR results showed that five (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, and hsa-miR-320b) of them were increased more than 10-fold (P < .001); four (hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, hsa-miR-320c) more than five-fold (P < .001); two (hsa-miR-342-3p and hsa-miR-320d) more than two-fold (P < .05); and two (hsa-miR-328-3p and hsa-miR-320e) more than two-fold (P > .05). Specifically, hsa-miR-22-3p increased 14.6-fold; hsa-miR-223-3p increased 13.0-fold; and hsa-miR-21-5p increased 12.0-fold. Based on bioinformatics functional analysis, target genes of top nine microRNAs (hsa-miR-22-3p, hsa-miR-223-3p, hsa-miR-21-5p, hsa-miR-23a-3p, hsa-miR-320b, hsa-let-7a-5p, hsa-miR-25-3p, hsa-miR-126-3p, and hsa-miR-320c) were annotated with positive regulation of cell proliferation and nervous system development, and mainly enriched in regulating pluripotency of stem cells signaling pathway, prolactin signaling pathway, and FoxO signaling pathway, etc. The prolactin, FoxO, ErbB, and TNF signaling pathway were relevant to immunomodulation. In particular, hsa-miR-22-3p expression was the most different during storage, with a fold change of 14.6, which might be a key mediator. SN - 1369-1635 UR - https://www.unboundmedicine.com/medline/citation/35968647/Differential_expression_of_exosomal_microRNAs_in_fresh_and_senescent_apheresis_platelet_concentrates_ DB - PRIME DP - Unbound Medicine ER -